Linaclotide 145 micrograms
LIN-MD-40
Phase 2 small_molecule completed
Quick answer
Linaclotide 145 micrograms for Opioid-Induced Constipation is a Phase 2 program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IRONWOOD PHARMACEUTICALS INC
- Indication
- Opioid-Induced Constipation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed